StockData
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) income statement

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$11.07+0.04 (+0.36%)

Close on Nov 20, 2026Market cap $942.13MP/E –Yield –

See a number that looks wrong?